Sugi Predict

Sugi Predict / Compounds / SCHEMBL338742

SCHEMBL338742

SCHEMBL338742

O=C(O)C(Cc1ccccc1)(Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ FDPS P14324 1/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CES1 P23141 2/20 0.48
▸ CES2 O00748 1/20 0.48
▸ AKR1B1 P15121 1/20 0.48
▸ PTPN1 P18031 3/20 0.45
▸ KEAP1 Q14145 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ TAAR1 Q96RJ0 1/20 0.44
▸ PTPN2 P17706 1/20 0.44
▸ PTPRA P18433 1/20 0.44
▸ PTPRB P23467 1/20 0.44
▸ ARG1 P05089 1/20 0.43
▸ ARG2 P78540 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21268824 0.98 SMN1; SMN2 (0.59) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL21269594 0.98 SMN1; SMN2 (0.59) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL21269769 0.98 SMN1; SMN2 (0.59) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL6575011 0.87 SMN1; SMN2 (0.53) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL7434259 0.87 SMN1; SMN2 (0.53) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL395522 0.87 SMN1; SMN2 (0.53) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL21269242 0.85 SMN1; SMN2 (0.52) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL28314726 0.85 SMN1; SMN2 (0.52) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL21269319 0.85 SMN1; SMN2 (0.52) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9
SCHEMBL21269412 0.85 SMN1; SMN2 (0.52) SMN1; SMN2HIF1AFDPSCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118909171-A Solid catalyst component for olefin polymerization reaction, preparation method and application thereof 中国石油化工股份有限公司 2024-11-08 — — CN claimed
CN-104558292-A Preparation method of catalyst for olefin polymerization CHINA PETROLEUM & CHEMICAL 2015-04-29 — — CN claimed
CN-104558290-A Components of catalyst for polymerization of olefins and catalyst CHINA PETROLEUM & CHEMICAL 2015-04-29 — — CN claimed
CN-104558291-A Preparation method of catalyst for olefin polymerization CHINA PETROLEUM & CHEMICAL 2015-04-29 — — CN claimed
CN-104558293-A Catalyst component for olefin polymerization and catalyst CHINA PETROLEUM & CHEMICAL 2015-04-29 — — CN claimed
EP-2780762-A1 COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE Ashwin-Ushas Corporation, Inc. (US) 2014-09-24 — — EP claimed
CN-104040417-A Complimentary polymer electrochromic device ASHWIN USHAS CORP INC 2014-09-10 — — CN claimed
WO-2013074702-A1 COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE ASHWIN-USHAS CORPORATION, INC. (US) 2013-05-23 — — WO claimed
US-20130120821-A1 COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE ASHWIN-USHAS CORPORATION, INC. (US) 2013-05-16 — — US claimed
EP-1732899-B1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S R L (IT) 2011-09-21 — — EP claimed
US-7381823-B2 Process for preparing cyclohexanediacetic acid monoamide SERICHIM S.R.L. (IT) 2008-06-03 — — US claimed
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2007-09-06 — — US claimed
EP-1732899-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHUM S.R.L. (IT) 2006-12-20 — — EP claimed
WO-2005090310-A2 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE SERICHIM S.R.L. (IT) 2005-09-29 — — WO claimed
EP-0002260-B1 MALONIC ACID DERIVATIVES OF STERICALLY HINDERED PIPERIDINES, PROCESS FOR THEIR PREPARATION AND STABILISED ORGANIC MATTER CIBA-GEIGY AG (CH) 1982-07-14 — — EP claimed
CN-110790896-B Blocked polyisocyanate and aqueous coating composition containing same ＫＣＣ公司 2022-01-28 — — CN disclosed
CN-109678998-B Catalyst component and catalyst system for olefin polymerization, prepolymerized catalyst system and olefin polymerization method 中国石油化工股份有限公司 2021-11-19 — — CN disclosed
US-4314933-A 2,2,6,6-TETRAALKYLPIPERIDINE COMPOUNDS CIBA-GEIGY CORPORATION (US) 1982-02-09 — — US disclosed
US-4278589-A 2-[2-Hydroxy-3,5-di-(α,α-dimethylbenzyl)phenyl]-2H-benzotriazole and stabilized compositions CIBA-GEIGY CORPORATION (US) 1981-07-14 — — US disclosed
US-4278590-A AUTOMOBILE FINISHES CIBA-GEIGY CORPORATION (US) 1981-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208175-A1 PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE GNPAT, GMDS, PIGS SMN1; SMN2 3584/4885HIF1A 995/4885FDPS 34/4885
US-20130120821-A1 COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE PMS2, PARG, EED SMN1; SMN2 3634/4885HIF1A 3897/4885FDPS 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.